RecallDepth
Class II Terminated

Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-590-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India

This recall has been terminated (originally issued November 27, 2024).

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
October 23, 2024
Posted
November 27, 2024
Recall Number
D-0053-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
146,322 bottles
Firm Location
Baltimore, MD, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Distribution

Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.

Lot / Code Info

a) NDC 68180-590-09; Lots G326928, exp. date 30-Sep-25, GA00964, exp. date 31-Dec-25, b) NDC 68180-590-01, Lots G326897, G326929, exp. date 30-Sep-25, GA00854, GA00933, GA00954, exp. date 31-Dec-25, c) NDC 68180-590-02, Lot GA00955, exp. date 31-Dec-25

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls